Institutional & Family Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $5.89M | Sell |
6,502
-491
| -7% | -$393K | 0.9% | 21 |
|
|
2024
Q1 | $5.44M | Sell |
6,993
-2,067
| -23% | -$1.47M | 0.87% | 22 |
|
|
2023
Q4 | $5.28M | Sell |
9,060
-657
| -7% | -$383K | 0.87% | 26 |
|
|
2023
Q3 | $5.22M | Sell |
9,717
-2,373
| -20% | -$1.22M | 0.85% | 30 |
|
|
2023
Q2 | $5.67M | Sell |
12,090
-1,759
| -13% | -$738K | 0.92% | 25 |
|
|
2023
Q1 | $4.76M | Buy |
13,849
+280
| +2% | +$94.4K | 0.78% | 40 |
|
|
2022
Q4 | $4.96M | Sell |
13,569
-1,864
| -12% | -$661K | 0.82% | 33 |
|
|
2022
Q3 | $4.99M | Buy |
15,433
+127
| +0.8% | +$40.2K | 0.88% | 26 |
|
|
2022
Q2 | $4.96M | Buy |
15,306
+241
| +2% | +$72.3K | 0.86% | 27 |
|
|
2022
Q1 | $4.31M | Buy |
15,065
+159
| +1% | +$40.9K | 0.68% | 36 |
|
|
2021
Q4 | $4.12M | Sell |
14,906
-1,677
| -10% | -$425K | 0.64% | 46 |
|
|
2021
Q3 | $3.83M | Sell |
16,583
-2,335
| -12% | -$576K | 0.61% | 52 |
|
|
2021
Q2 | $4.34M | Buy |
18,918
+2,565
| +16% | +$515K | 0.72% | 34 |
|
|
2021
Q1 | $3.06M | Sell |
16,353
-1,036
| -6% | -$203K | 0.59% | 54 |
|
|
2020
Q4 | $2.94M | Sell |
17,389
-363
| -2% | -$54.2K | 0.62% | 57 |
|
|
2020
Q3 | $2.63M | Sell |
17,752
-2,053
| -10% | -$318K | 0.61% | 64 |
|
|
2020
Q2 | $3.25M | Sell |
19,805
-962
| -5% | -$148K | 0.67% | 53 |
|
|
2020
Q1 | $2.88M | Sell |
20,767
-2,574
| -11% | -$354K | 0.66% | 56 |
|
|
2019
Q4 | $3.07M | Sell |
23,341
-3,027
| -11% | -$351K | 0.65% | 62 |
|
|
2019
Q3 | $2.95M | Sell |
26,368
-87
| -0.3% | -$9.69K | 0.65% | 63 |
|
|
2019
Q2 | $2.93M | Buy |
26,455
+766
| +3% | +$90.2K | 0.63% | 64 |
|
|
2019
Q1 | $3.33M | Sell |
25,689
-1,746
| -6% | -$212K | 0.7% | 55 |
|
|
2018
Q4 | $3.17M | Sell |
27,435
-9,598
| -26% | -$1.07M | 0.71% | 41 |
|
|
2018
Q3 | $3.97M | Sell |
37,033
-973
| -3% | -$97.3K | 0.79% | 33 |
|
|
2018
Q2 | $3.24M | Sell |
38,006
-4,069
| -10% | -$334K | 0.68% | 55 |
|
|
2018
Q1 | $3.25M | Sell |
42,075
-7,697
| -15% | -$620K | 0.69% | 59 |
|
|
2017
Q4 | $4.2M | Buy |
49,772
+3,423
| +7% | +$291K | 0.8% | 56 |
|
|
2017
Q3 | $3.96M | Sell |
46,349
-1,338
| -3% | -$110K | 0.8% | 41 |
|
|
2017
Q2 | $3.92M | Buy |
47,687
+832
| +2% | +$67.9K | 0.96% | 31 |
|
|
2017
Q1 | $3.94M | Buy |
46,855
+1,496
| +3% | +$120K | 1.23% | 26 |
|
|
2016
Q4 | $3.34M | Buy |
45,359
+727
| +2% | +$54.1K | 1.05% | 52 |
|
|
2016
Q3 | $3.58M | Buy |
44,632
+3,289
| +8% | +$263K | 1.19% | 32 |
|
|
2016
Q2 | $3.26M | Buy |
41,343
+11,200
| +37% | +$843K | 1.13% | 40 |
|
|
2016
Q1 | $2.54M | Sell |
30,143
-68
| -0.2% | -$5.14K | 0.95% | 50 |
|
|
2015
Q4 | $2.55M | Buy |
+30,211
| New | +$2.51M | 0.95% | 50 |
|
Other funds holding LLY
Institutional & Family Asset Management's LLY Position: Q2 2024 in Review
Institutional & Family Asset Management reduced its Eli Lilly (LLY) stake by 7% in Q2 2024, selling an estimated $393K and leaving 6,502 shares worth $5.89M. The position accounts for 0.9% of the portfolio, ranked #21.
Institutional & Family Asset Management first reported a position in LLY in Q4 2015 and has held it in 35 quarters since. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.
- Institutional & Family Asset Management held 6,502 shares of Eli Lilly worth $5.89M as of Q2 2024.
- Institutional & Family Asset Management sold 491 Eli Lilly shares in Q2 2024, an estimated $393K.
- Eli Lilly made up 0.9% of Institutional & Family Asset Management's portfolio in Q2 2024, its #21 holding.
- Institutional & Family Asset Management first reported a position in Eli Lilly in Q4 2015 and has held it in 35 quarters since.
- 3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.
Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.